<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00133081</url>
  </required_header>
  <id_info>
    <org_study_id>SITE</org_study_id>
    <nct_id>NCT00133081</nct_id>
  </id_info>
  <brief_title>Study to Improve the Treatment of Epilepsy (SITE)</brief_title>
  <official_title>Study to Improve the Treatment of Epilepsy (SITE). A Randomized Study Comparing Adjustment of Treatment to Reduce Side Effects of Antiepileptic Drugs With Continuing Treatment Unchanged</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>UMC Utrecht</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>GlaxoSmithKline</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>UMC Utrecht</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess whether changing antiepileptic medication can reduce&#xD;
      side effects and improve the quality of life in patients with epileptic seizures that are&#xD;
      well controlled with antiepileptic drugs.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background. The aim of the treatment with antiepileptic drugs (AEDs) is to achieve seizure&#xD;
      freedom without causing side effects. Assessment of side effects is difficult. They may start&#xD;
      insidiously, the patient may not associate certain complaints with the use of AEDs, or the&#xD;
      treating physician does not take enough time to discuss this topic during the limited time of&#xD;
      a visit in the outpatient department. We know from clinical trials that side effects occur in&#xD;
      a substantial group of patients. We do not know whether we deal with this possible&#xD;
      complication in an adequate way in clinical practice.&#xD;
&#xD;
      Study objective. To study whether adjustment of medication will reduce the occurrence of side&#xD;
      effects and improve quality of life.&#xD;
&#xD;
      Study design. A randomised clinical trial comparing adjustment of treatment in case of&#xD;
      relevant side effects to continuing treatment unchanged. Relevant side effects are defined as&#xD;
      at least one moderate or serious problem scored on a questionnaire to assess complaints in&#xD;
      people with epilepsy.&#xD;
&#xD;
      Patients who do not report relevant side effects will be followed for 13 months (arm A) in&#xD;
      which two visits are scheduled, after 7 and 13 months respectively.&#xD;
&#xD;
      The patients who do report relevant side effects will be randomised to either discussion of&#xD;
      the questionnaire results and adjustment of treatment if appropriate (arm B) or to ignore the&#xD;
      results of the questionnaire and continue treatment unchanged (arm C). Investigations will be&#xD;
      repeated in both groups after 7 and 13 months after the initial visit.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>October 2002</start_date>
  <completion_date>August 2006</completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Complaints (questionnaire) at 7 and 13 months</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of Life (Qolie-10) at 7 and 13 months</measure>
  </secondary_outcome>
  <enrollment>255</enrollment>
  <condition>Epilepsy</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>All registered antiepileptic drugs</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Aged 18 years or older&#xD;
&#xD;
          -  Treatment: antiepileptic drugs for epilepsy&#xD;
&#xD;
          -  No change in medication during last 6 months&#xD;
&#xD;
          -  No obvious clinical reason to change medication immediately&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Concurrent disease or disorder that might interfere with the conduct of the study&#xD;
&#xD;
          -  Inability to comply to the protocol&#xD;
&#xD;
          -  Impaired intellectual functioning, leading to inability to comply to the protocol and&#xD;
             complete the necessary questionnaires&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Cees A van Donselaar, MD PhD</last_name>
    <role>Study Director</role>
    <affiliation>UMC Utrecht</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sabine G Uijl, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>UMC Utrecht</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Albert P Aldenkamp, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>AZM Maastricht</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Cuno SP Uiterwaal, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UMC Utrecht</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>AZM</name>
      <address>
        <city>Maastricht</city>
        <state>Limburg</state>
        <zip>6202 AZ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Catharina Hospital</name>
      <address>
        <city>Eindhoven</city>
        <state>Noord Brabant</state>
        <zip>5623 EJ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Gooi-Noord</name>
      <address>
        <city>Blaricum</city>
        <state>Noord Holland</state>
        <zip>1250 CA</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oosterschelde Hospital</name>
      <address>
        <city>Goes</city>
        <state>Zeeland</state>
        <zip>4460 BB</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MCRZ</name>
      <address>
        <city>Rotterdam</city>
        <state>Zuid Holland</state>
        <zip>3007 AC</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MC Haaglanden</name>
      <address>
        <city>The Hague</city>
        <state>Zuid Holland</state>
        <zip>2512 VA</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>March 2004</verification_date>
  <study_first_submitted>August 17, 2005</study_first_submitted>
  <study_first_submitted_qc>August 17, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 22, 2005</study_first_posted>
  <last_update_submitted>October 20, 2005</last_update_submitted>
  <last_update_submitted_qc>October 20, 2005</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 21, 2005</last_update_posted>
  <keyword>epilepsy</keyword>
  <keyword>antiepileptic drugs</keyword>
  <keyword>side effects</keyword>
  <keyword>quality of life</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Epilepsy</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anticonvulsants</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

